Shanxiang Jiang

Prof. Dr. Shanxiang Jiang

Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Nanjing Agri-cultural University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
HNHan Ni
Han Ni
LPLin Peng
Lin Peng
XGXiuge Gao
Xiuge Gao
HJHui Ji
Hui Ji
JMJunxiao Ma
Junxiao Ma
SJShanxiang Jiang
Shanxiang Jiang

28 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
YGYing Gao
Ying Gao
HJHui Ji
Hui Ji
LPLin Peng
Lin Peng
Xiuge GaoXiuge Gao
Xiuge Gao
SJShanxiang Jiang
Shanxiang Jiang
The highly contagious Newcastle disease virus (NDV) continues to threaten poultry all over the world. The NDV DNA vaccine is a promising solution to the current Newcastle disease (ND) challenges, and thus an efficient delivery system should be developed to facilitate the efficacy of DNA vaccines. In this study, we developed a DNA vaccine delivery system consisting of a triblock copolymer of poly(lactide co-glycolide acid) and polyethylene glycol (PLGA-PEG-PLGA) hydrogel in which the recombinant NDV hemagglutinin-neuraminidase (HN) plasmid was encapsulated. Its characteristics, security, immune responses, and efficacy against highly virulent NDV were detected. The results showed that the plasmids were gradually released in a sustained manner from the hydrogel, which improved the biological stability of the plasmids and demonstrated a high biocompatibility. The plasmids, when they were incorporated into the hydrogel delivery system, enhanced immune activation and provided 100% protection against the highly virulent NDV strain. Furthermore, we proved that this NDV DNA hydrogel vaccine could improve the lymphocyte proliferation and increase the immunological cytokine production via the PI3K/Akt pathway. These results indicate that the PLGA-PEG-PLGA thermosensitive hydrogel could be a promising delivery system for the NDV DNA vaccine in order to achieve a sustained supply of plasmids and induce potent immune responses.

1 March 2021 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
XGXiuge Gao
Xiuge Gao
XLXiaoxiao Liu
Xiaoxiao Liu
XSXinhao Song
Xinhao Song
PTPei Teng
Pei Teng
HJHui Ji
Hui Ji
SJShanxiang Jiang
Shanxiang Jiang
Maduramicin, an extensively used anticoccidial drug, has been introduced into environment due to poorly absorbed in the intestine of broiler chicken. To understand the potential ecological toxicity of maduramicin on aquatic organisms, acute and subacute toxicity, hemolymph biochemistry, histopathology and the expressions of drug metabolism and stress response genes of crayfish (Procambius clarkii) were investigated in this study. For the first time, the 96 h median lethal concentration (LC50) of maduramicin on crayfish was 67.03 mgL-1 with a 95% confidence interval (54.06-81.32 mgL-1). Then, the crayfish were exposed to 0.7 mgL-1 (1/100 LC50), 3.5 mgL-1 (1/20 LC50) and 7.0 mgL-1 (1/10 LC50) maduramicin for 28 days. Maduramicin significantly altered biochemical parameters including AST, ALT, CK, LDH and ALP of hemolymph in crayfish at several time points. The activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) of crayfish gills, hepatopancreas and abdominal muscle were significantly decreased or elevated by different concentrations of maduramicin treatment at varying time points. Furthermore, histopathological damage of crayfish gills, hepatopancreas and abdominal muscle were observed in a concentration-dependent manner. The expressions of metabolic and stress response genes (CYP450, GST, COX1, COX2, HSP70 and MT) in hepatopancreas of crayfish were significantly up-regulated by maduramicin (7.0 mgL-1) treatment for 8 h to 7 d, and returned to normal levels after the removal of maduramicin for 3-7 days. In conclusion, our findings demonstrated that environmental exposure of maduramicin threaten to the health of crayfish living in the areas nearby livestock farms or pharmaceutical factory. Crayfish exhibited resistance to the stress of maduramicin via activating drug metabolite and detoxification pathways.

1 February 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
DGDawei Guo
Dawei Guo
JZJunren Zhang
Junren Zhang
ZHZhihai Huang
Zhihai Huang
SJShanxiang Jiang
Shanxiang Jiang
NGNing Gu
Ning Gu

22 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XCXin Chen
Xin Chen
YGYing Gu
Ying Gu
KSKarnika Singh
Karnika Singh
CSChaowei Shang
Chaowei Shang
MBMansoureh Barzegar
Mansoureh Barzegar
Shile HuangShile Huang
Shile Huang
Maduramicin, a polyether ionophore antibiotic derived from the bacterium Actinomadura yumaensis, is currently used as a feed additive against coccidiosis in poultry worldwide. It has been clinically observed that maduramicin can cause skeletal muscle and heart cell damage, resulting in skeletal muscle degeneration, heart failure, and even death in animals and humans, if improperly used. However, the mechanism of its toxic action in myoblasts is not well understood. Using mouse myoblasts (C2C12) and human rhabdomyosarcoma (RD and Rh30) cells as an experimental model for myoblasts, here we found that maduramicin inhibited cell proliferation and induced cell death in a concentration-dependent manner. Further studies revealed that maduramicin induced accumulation of the cells at G0/G1 phase of the cell cycle, and induced apoptosis in the cells. Concurrently, maduramicin downregulated protein expression of cyclin D1, cyclin-dependent kinases (CDK4 and CDK6), and CDC25A, and upregulated expression of the CDK inhibitors (p21Cip1 and p27Kip1), resulting in decreased phosphorylation of Rb. Maduramicin also induced expression of BAK, BAD, DR4, TRADD and TRAIL, leading to activation of caspases 8, 9 and 3 as well as cleavage of poly ADP ribose polymerase (PARP). Taken together, our results suggest that maduramicin executes its toxicity in myoblasts at least by inhibiting cell proliferation and inducing apoptotic cell death.

11 November 2017 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
XGXiuge Gao
Xiuge Gao
LPLin Peng
Lin Peng
XRXiangchun Ruan
Xiangchun Ruan
XCXin Chen
Xin Chen
HJHui Ji
Hui Ji
Dawei GuoDawei Guo
Dawei Guo